Sample Collection for Clinical Analysis

A clinical laboratory is responsible for obtaining information on the health status of a person, through the analysis of biological samples on which tests are performed to measure a series of indicators of various kinds: hematological, immunological, microbiological, biochemical, parasitological, toxicological, etc. At the CEM, samples of blood, urine, saliva and stool are taken and analysed and are a fundamental tool for the doctor to make diagnostic, therapeutic and prognostic decisions.


  • Conventional tests (blood, urine, saliva and stool).
  • Neobona genetic test (blood): analysis based on the patient’s DNA or RNA, which consists of the non-invasive screening of T21, T18, T13 and optional determination of fetal sex by NGS sequencing with PAIRED-END readings (1 or 2 fetuses).
  • Test A200 Food Intolerance (blood): study of hypersensitivity to 218 foods of the Mediterranean diet (IgG).
  • Migratest test (blood): determination of the activity of the DAO enzyme to degrade histamine ingested through the diet as a possible cause of migraine.
  • BRCA1 & BRCA2 genetic test (NGS + MLPA): molecular study of BRCA1 and BRCA2 related to hereditary breast and ovarian cancer (NGS + MLPA sequencing). Analysis based on the patient’s DNA or RNA.
  • Colonplus genetic test: molecular study of 16 genes related to hereditary gastrointestinal cancer (NGS + MLPA sequencing in MSH2, MLH1, APC, MSH6, EPCAM and PMS2). Analysis based on the patient’s DNA or RNA.
  • PROPSA test: analysis of [-2] PROPSA, PSA and fPSA to establish the prostate health index (PHI), which determines the risk of prostate cancer.